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Abstract— This paper presents a method for building patient-based networks that we call Precision 
disease networks, and its uses for predicting medical outcomes. 
Our methodology consists of building networks, one for each patient or case, that describes the 
disease evolution of the patient (PDN) and store the networks as a set of features in a dataset of 
PDN’s, one per observation. We cluster the PDN data and study the within and between cluster 
variability.  In addition, we develop data visualization technics in order to display, compare and 
summarize the network data.  Finally, we analyze a dataset of heart diseases patients from a New 
Jersey statewide database MIDAS (Myocardial Infarction Data Acquisition System, in order to show 
that the network data improve on the prediction of important patient outcomes such as death or 
cardiovascular death, when compared with the standard statistical analysis. 
Index Terms—Big Data, networks, bayessian networks, cardiovascular diseases. 
——————————   ◆   —————————— 
1 INTRODUCTION
In modern medicine, networks have been used to 
represent pathways of diseases. In functional genomics 
researchers build biological pathways representing the 
mechanisms of certain processes. In cardiology and more 
generally in medicine, and in many other areas, researchers 
build graphs or pathways that summarize the working 
mechanisms of a certain process or disease. 
In this paper we use the word network to represent a 
data construction in a form of a connected graph, 
representing the pathway of a disease. Note that in general 
this can model the pathway of any process. Such a network 
can then be analyzed to reveal medical insights. For 
example, in Neurology it is possible to build physical 
networks that represent real connections in a subject’s 
brain and the dataset of brain networks have been analyzed 
using a Bayesian model [1] [2][3].   
In cardiovascular diseases, while we do not have a 
physical network of connections, we do observe 
relationships.  In this paper, we propose to build individual 
patient networks, which represent the disease evolution of 
patients across subsequent hospitalizations. These 
networks, like the neurology networks, are individual based 
and represent the evolutionary steps of various 
cardiovascular conditions, diseases and procedures. 
Bayesian networks (BN) have been proposed in the past 
as tools for building networks. But the methodology of BN 
is to build one network for one dataset or subset that has 
been selected. This approach does not work here because 
each patient has a different disease progression and 
physicians believe that most cardiovascular diseases occur 
in many different ways. Therefore one single network or a 
top down approach may not capture this variability in most 
cases. Instead we propose the idea of building one network 
for each patient, which we term as personalized disease 
networks (PDN). As a result we obtain a dataset of PDN’s. 
Then we cluster the PDN’s by projecting to the principal 
components space and use the clusters as follows: 
(i)  Clusters are summarized as networks representing a 
diversity of disease evolution pathways for the groups of 
patients in our dataset. 
(ii) Predict clinical outcomes such as 1 year or 5 years 
cardiovascular death, stroke, and other. We expect that 
different networks correspond to different survival 
probabilities or distributions. 
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2 THE MIDAS DATABASE AND AN EXAMPLE 
The MIDAS database [4] contains all hospitalizations for 
cardiovascular diseases in New Jersey since. The MIDAS 
database contains the records of 15 million 
hospitalizations for 5 million patients with cardiovascular 
diseases. We apply our network methodology to MIDAS 
data and build patient networks for cardiovascular 
diseases. MIDAS contains the demographic information of 
the patients as well as the ICD9 codes for the diseases and 
the procedural codes.  
Example: For this study we select a subset of MIDAS 
containing those patients who were admitted for an event 
of heart failure (HF) or atrial fibrillation (AFIB) or both. The 
medical experts selected a total of 36 conditions that 
maybe related to HF or AFIB. For simplicity we restricted 
ourselves to the subset of African American patients. 
The first step of our methodology is to build the PDN’s 
from the data. In our study, we use African American 
patient subset to precede the analysis. 
3. BUILDING PDN’S. 
Medical records in MIDAS include for each patient a list 
of all the hospitalizations together with dates and ICD9 
codes that are diagnosed. These codes represent all the 
cardiovascular events and conditions that happened during 
the hospitalization. This information was used to build the 
edges of the PDN’s following a set of rules. 
Our network is made up of nodes 1,…,p that may be 
connected by directed edges from one node to another, 
which we will call arrows.Suppose that a patient has an 
episode of atrial fibrillation (AFIB) followed by an episode 
of heart failure (HF). If the time elapsed between both 
episodes is less than a threshold , then we will add an 
arrow from the AFIB node to the HF node. If the reverse 
were to happen at a different point in time the opposite 
arrow will also be added to the network. The following 
algorithm implements this idea.   
 (i) Start with a data matrix $A$ containing n rows (patients) 
and $p$ columns (events) giving the dates of the events 
corresponding to each patient. If the i-th patient never had 
the j-th event the corresponding entry in the dataset 
should be empty or NA (not available).  
(ii) For the i-th patient build a network (PDN) with nodes 
N1,…,Nk(i), representing the list of events that occurred to 
the i-th patient of length k(i) out of p and have a non empty 
entry in the i-th row the matrix A. If 0 < A[i,l] –A[i,j] <   jl  
then one edge of the network will connect nodes j and l 
with an arrow from node j to node l, otherwise there will be 
no connection. In this way, the adjacency network matrix M 
is built.  jl is a threshold that is provided by the medical 
experts or a combination of medical expertise with data 
driven methodldogy that will be discused later. 
(iii) For every pair of nodes j and l step (ii) will be repeated 
in both directions so it is possible to have two arrows one 
from j to l and another from l to j. Also it is possible to have 
only one arrow or no arrows. The arrows between j and l 
are recorded by two dummy variables jtol and ltoj, which 
will take values of 1 or 0 representing arrow or no arrow. 
(iv) After repeating steps (ii) and (iii) for all n subjects we 
obtain a network matrix M of n rows and p×(p-1) columns, 
two columns for every pair of I and J. The rows of M 
represent the individual networks of the n subjects.  
Fig. 1 depicts the result of the above algorithm applied 
to the data from patient no. 28 in our example dataset that 
is described in section 2. The list of events and dates for 
this patient is shown in the middle of the figure. The events 
are ordered by date of occurrence and the arrows represent 
the relationships satisfying a given set of rules.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.a Graph of PDN for patient number 28 on our dataset. The table 
in the middle of the graph shows the sequence of codes and dates for 
the paptient 
 
4. CLUSTERING PDN’S AND DIMENSION REDUCTION. 
The matrix M contains a diversity of networks that 
represent different ways of disease evolution or different 
pathways, one per subject. However, it may be possible to 
summarize the disease evolution using just a few network 
summaries that are followed by a large majority of the 
patients. One simple way to do this is to apply a hierarchical 
clustering or any equivalent algorithm to the subject’s data, 
or rows of M. Since the dimensionality of M can be quite 
large it is recommended to reduce the dimension by using 
principal components analysis (PCA) prior to clustering [5]. 
In particular we apply enriched PCA which is a weighted 
version of PCA that gives less importance to variables 
whose relationship to the outcome variable is explained by 
chance [6]. If a response variable is available the weights s 
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Fig 1.b has a idealization of the graph in Fig 1.a 
5. DATA ANALYSIS AND RESULTS 
Our example dataset contains a total of 4500 patients 
that complied with our inclusion criteria. In MIDAS there are 
other subsets of interest with millions of subjects but for 
the purpose of illustrating the PDN methodology we 
consider only African American subjects that have been 
diagnosed with hear failure (HF), atrium fibrillation (AFIB) 
or both. 
The objective of this example is to understand the 
relationship between AFIB and HF and the pathways in 
which AFIB precedes HF and the reverse in which HF 
precedes AFIB. For this example we consider 36 
comorbidities including myocardial infarction (MI), stroke 
(STR), hypertension (HTN) and others. The picture in Figure 
1 depicts the PDN for patient no. 28 in our datatset of 4500 
PDN’s. For this dataset we implemented the following data 
analysis plan: 
1. Build the matrix of personalized disease networks 
according to the hospitalization records and the set of rules 
or thresholds that are obtained provided by the expert 
physicians or that are derived from the data. 
2. Apply enriched PCA [6] or a nonlinear PCA method [7] to 
determine the principal components. 
3. Perform the hierarchical clustering on a reduced set of 
principal components and screen for the optimal numbers 
of clusters. 
 
Fig.2 10 principal component clusters.  PDNs were clustered using 43 
enrichedprincipal components of the adjacent matrix. The clusters 
were plotted against the 1st and 2nd principal components. 
Fit prediction models that could be linear, logistic, poisson 
or cox regression models depending on the type of 
respose. The predictors are grouped in 4 blocks which are 
(i) Age and Gender, (2) 36 comorbidities (3) k PCA’s 
summary of the set of PDN’s and, (iv) Cluster factor. Table 1 
shows the R2 for 7 models of interest that are ciombinations 
of these groups. The two columns representing the results 
derived form the summary of the PDN dataset using Linear 
and non-linear PCA respectively.  
5.  Consider a hierarchy of models that combine datasets 
(i) through (iv) as the 7 models in Table 1 and perform 
likelihood ratio chi-square tests comparing models in the 
hierarchy in order to establish the importance of the PDN 
and cluster datasets ((iii) and (iv)). 
In our study we obtained two versions of the PDN matrix 
M1 using data driven thresholds, and M2 using no 
threshold, that is setting all  IJ‘s to infinity. We performed 
parallel analyses for these two datasets. 
For step 2 we considered two methods for PCA, enriched 
PCA [5] and nonlinear PCA[7]and from the SCREE plots we 
reduced the dimension to 43 principal componets for each 
of the two analyses of the 2 datasets which resulted in 4 
pricipal componets datsets.  
   
Patient 28 
COPD 
BACT 
HYPO 
RENAL 
HF 
HTN 
DYSR 
PNEM
 
ANENMIA 
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Fig.3. Summary graph of ten clusters of PDN’s. The arrows represent 
the frequency of the relationship from A to B in the cluster of patients, 
Red arrows represente a frequency of 75% or more of the cluster 
observations containinig the relationship, green arrows represent a 
frequency in the range 50%- 75%, whereas yellow arrows represent 
represent a frequency in the range 25%-50%. 
For step 3 we performed a hierarchical cluster analysis 
using the WARD method that resulted in 10 clusters for 
each of the 4 PCA datasets. Figure 2 shows a scatter plot of 
the first two components of the first of the cluster analysis 
where the 10 clusters are shown in different colors.  In 
Figure 3 we display the summaries of the 10 clusters. 
For step 4 we used the cox proportional hazard model 
with the variable “all death” as response that measures the 
date of death for any cause of death. We fitted 7 different 
models using different combinations of predictors as 
shown on table 1.  The best R2 (55%) was found for model 
7 and dataset 2 that corresponds to enriched principal 
components on the network dataset constructed using the 
data driven thresholds.  
Finally for the 5th step in table 1 we first compare models 
4 and 1 and conclude that the addition of the 
cardiovascular events improves the fit from the model with 
just demographics.  Then we show that the addition of the 
PDN variables also improves the fit not only in R2 but also 
is statistically very significant. On table 1, the line of Model 
6 vs model 5 shows that the addition of the cluster factor 
only improves the fit for the Nonlinear PCA datasets.   
Finally the results of model 7 vs model 5 shows that the use 
of clusters as a multiplicative variable results in statistically 
significant improvements for all but the linear PCA with 
infinity threshold. 
In summary the best model is model 7 for the PCA 
dataset with data driven thresholding because it greatly 
improves the likelihood as compared to any other model 
and has a much higher R2 than any of the other models. 
7 CONCLUSION 
The results shown here demonstrate the methodology of 
building personalized disease networks. They also show 
that PDN’s improve the R2 and goodness of fit with respect 
to the standard models and also show that the 
improvements are substancial in terms of R2. Therefore, this 
establishes the effectiveness of PDNs, albeit in a 
preliminary study. We plan to explore this in the future.  
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TABLE 1 
COMPARISONS OF 7 MODELS TO PREDICT ALL DEATH 
IN 4 DIFFERENT DATASETS OF PRINCIPAL 
COMPONENTS DERIVED FROM PDN DATSETS.    
  PCA no 
cut (11 
clusters) 
PCA with 
cut (10 
clusters) 
NLPCA no 
cut (10 
clusters) 
NLPCA with 
cut (10 
clusters) 
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R  square         
1. age+ sex 0.064 0.064 0.064 0.064 
2. disease 
condition 
0.11 0.11 0.11 0.11 
3. network 
variables 
0.27 0.25 0.27 0.25 
4. age+ sex+ 
disease 
0.15 0.15 0.15 0.16 
5. age+sex+ 
disease+ 
network 
0.28 0.28 0.28 0.28 
6. age+sex+ 
disease+ 
network+ 
clusters 
0.28 0.28 0.27 0.27 
7. age+sex+ 
disease+ 
network * 
clusters 
0.37 0.55 0.31 0.32 
p-value 
    
model 
4/model 1 
0 0 0 0 
model 
4/model 5  
0 0 0 0 
model 
6/model 5  
0.1048 0.6919 8.59E-13 6.59E-13 
model 
7/model 5  
0.997 0 0.002567 
  
 0.000395 
 
